Acadia Pharma Stock Price (NASDAQ:ACAD)

Add to My Stocks
$39.2 $0.08 (0.2%) ACAD stock closing price Feb 21, 2017 (Closing)
Acadia Pharma
21 FEB 2017
amigobulls logo
ACAD hand_up
ACAD vs S&P 500
Closing Price: Feb 21, 2017
$39.2 ( -0.2%)
S&P 500
2365.4 ( 0.6%)
52 Week Price Range
1 Year Return: 95.23%
Q3 Growth*
Profitable ?
net image
2016 Q3 Net Loss
home image
☆ ☆ ☆ ☆ ☆★ ★ ★ ★ ★
Double Tap To Exit Full Screen

Acadia Pharma Snapshot Video

27 5 2

ACAD Stock Details

Prev Close* : $39.28
Market Cap:
Day Low: $38.68
52 Week Low: $17.02
Open: $39.54
Volume: 1842615
Day High: $40.02
52 Week High: $42.49

Latest Stock Market News

Latest Articles

Acadia Pharma News - From Partners

ACAD Stockcharts

View ACAD PE ratio, PS ratio stocks charts and compare with peers.
ACAD Chart
Note: Compare Acadia Pharma stock price history with the index and industry peers.

Acadia Pharma Valuation

PS ratio (
price to sales ratio
PB ratio (
price to book ratio

Acadia Pharma Financial Ratios

Asset Turnover
Receivables Turnover

ACAD Industry Peers

Company Price Change (%)
Dyax (DYAX)38.410 (0%)
Bioverativ Inc (BIVV)47.453.35 (7.6%)
Eli Lilly (LLY)80.360.03 (0.04%)
Pfizer (PFE)33.620 (0%)
Adamas Pharma (ADMS)17.20.08 (0.46%)
Axsome Therapeutics (AXSM)4.180.12 (2.79%)
Praxsyn (PXYN)0.010 (0%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
EXACT Sciences (EXAS)22.412.5 (12.56%)
Fate Therapeutics (FATE)4.380.45 (11.45%)
Nymox Pharmaceutical (NYMX)3.540.12 (3.51%)
Myriad Genetics (MYGN)19.080.46 (2.47%)
Stemline Therapeutics (STML)6.950.15 (2.21%)
Evogene (EVGN)5.4210.11 (2.07%)
OncoMed Pharma (OMED)8.910.18 (2.06%)
Top gainers from Medical-Biomed-Genetics industry
* As of Feb 21, 2017
CompanyPriceChange (%)
Trevena (TRVN)4.272.86 (40.11%)
Momenta Pharma (MNTA)16.052.95 (15.53%)
Peregrine Pharma (PPHM)0.4790.07 (12.73%)
Cytokinetics (CYTK)10.40.85 (7.56%)
Argos Therapeutics (ARGS)4.40.3 (6.38%)
Sorrento Therapeutics (SRNE)5.250.3 (5.41%)
Immunomedics (IMMU)5.060.28 (5.24%)
Top losers from Medical-Biomed-Genetics industry
* As of Feb 21, 2017

Acadia Pharma Financial Statements

income statement20152014201320122011
Net Sales Or Revenues0.06M0.12M1.14M4.9M2.06M
Net Income-164.44M-92.47M-37.94M-20.84M-22.76M
Total Operating Expense164.66M93.34M39.44M25.78M24.91M
view ACADIA Pharmaceuticals Inc. income statement
balance sheet20152014201320122011
Total Assets221.89M325.45M189.11M108.59M32.11M
Total Liabilities22.13M15.96M6.98M23.6M8.75M
Shareholders Equity199.76M309.48M182.13M84.98M23.36M
view ACADIA Pharmaceuticals Inc. balance sheet
cash flow statement20152014201320122011
Net Increase (Decrease) In Assets Liabilities4.11M9.31M-1.12M-2.43M0.07M
Net Cash From (Used By) Operating Activities-121.79M-66.43M-31.76M-21.63M-19.89M
Increase (Decrease) In Prop Plant And Equipment-2.14M-0.18M-0.6M0.25M-
view ACADIA Pharmaceuticals Inc. cashflow statement

ACADIA Pharmaceuticals Inc. Stock News - Partner Headlines

Acadia Pharma Stock Message Board

As of last trading day, Acadia Pharma stock price was 39.28. The total market value as denoted by 4.76B for Acadia Pharma, is the market value of the company's outstanding shares. Acadia Pharma valuation can be guaged using various valuation metrics like the price to earnings ratio.

Demand for a stock decides its stock market price. For example, if more investors want to buy ACAD stock than sell it, then Acadia Pharma stock price goes up. Conversely, if more investors wanted to sell ACAD stock than buy it, there would be greater supply than demand, and the stock price would fall. The volume number in Acadia Pharma stock quote data shows the number of shares traded. For Ex: 1674691 Acadia Pharma shares were traded as of last trading day, as seen from Acadia Pharma stock chart. Dividends are usually paid by large stable companies, and typically not by those which are in their rapid growth stages. A company's continuing success is indicated by a steadily increasing dividend payout. Acadia Pharma stock price history, gives the entire historical data for ACAD stock.